Literature DB >> 15087991

Efficacy of ECT in depression: a meta-analytic review.

Daniel Pagnin1, Valéria de Queiroz, Stefano Pini, Giovanni Battista Cassano.   

Abstract

This study analyzed the efficacy of electroconvulsive therapy (ECT) in depression by means a meta-analytic review of randomized controlled trials that compared ECT with simulated ECT or placebo or antidepressant drugs and by a complementary meta-analytic review of nonrandomized controlled trials that compared ECT with antidepressants drugs. The review revealed a significant superiority of ECT in all comparisons: ECT versus simulated ECT, ECT versus placebo, ECT versus antidepressants in general, ECT versus TCAs and ECT versus MAOIs. The nonrandomized controlled trials also revealed a significant statistical difference in favor of ECT when confronted with antidepressants drugs. Data analyzed suggest that ECT is a valid therapeutic tool for treatment of depression, including severe and resistant forms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15087991     DOI: 10.1097/00124509-200403000-00004

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.635


  89 in total

1.  Racial differences in the availability and use of electroconvulsive therapy for recurrent major depression.

Authors:  Brady G Case; David N Bertollo; Eugene M Laska; Carole E Siegel; Joseph A Wanderling; Mark Olfson
Journal:  J Affect Disord       Date:  2011-12-12       Impact factor: 4.839

Review 2.  The history and future of deep brain stimulation.

Authors:  Jason M Schwalb; Clement Hamani
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

Review 3.  Targeting the hippocampal mossy fiber synapse for the treatment of psychiatric disorders.

Authors:  Katsunori Kobayashi
Journal:  Mol Neurobiol       Date:  2009-01-08       Impact factor: 5.590

Review 4.  Neuromodulation for treatment-refractory major depressive disorder.

Authors:  Nir Lipsman; Tejas Sankar; Jonathan Downar; Sidney H Kennedy; Andres M Lozano; Peter Giacobbe
Journal:  CMAJ       Date:  2013-07-29       Impact factor: 8.262

Review 5.  [Electroconvulsive therapy for the treatment of major depression].

Authors:  D Zilles; C Wolff-Menzler; J Wiltfang
Journal:  Nervenarzt       Date:  2015-05       Impact factor: 1.214

6.  Electroconvulsive shock enhances striatal dopamine D1 and D3 receptor binding and improves motor performance in 6-OHDA-lesioned rats.

Authors:  Elissa M Strome; Athanasios P Zis; Doris J Doudet
Journal:  J Psychiatry Neurosci       Date:  2007-05       Impact factor: 6.186

Review 7.  Therapeutic options for treatment-resistant depression.

Authors:  Richard C Shelton; Olawale Osuntokun; Alexandra N Heinloth; Sara A Corya
Journal:  CNS Drugs       Date:  2010-02       Impact factor: 5.749

8.  Pharmacological and combined interventions for the acute depressive episode: focus on efficacy and tolerability.

Authors:  Andre R Brunoni; Renerio Fraguas; Felipe Fregni
Journal:  Ther Clin Risk Manag       Date:  2009-11-18       Impact factor: 2.423

9.  Tianeptine: an antidepressant with memory-protective properties.

Authors:  Phillip R Zoladz; Collin R Park; Carmen Muñoz; Monika Fleshner; David M Diamond
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363

Review 10.  Packages of care for depression in low- and middle-income countries.

Authors:  Vikram Patel; Gregory Simon; Neerja Chowdhary; Sylvia Kaaya; Ricardo Araya
Journal:  PLoS Med       Date:  2009-10-06       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.